Corcept Therapeutics
Pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Learn more
Launch date
Employees
Market cap
€3.4b
Enterprise valuation
€3.0b (Public information from Sep 2024)
Share price
$42.25 CORT
Menlo Park California (HQ)
Authorizing premium user...